Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

Parkinson’s can cause a condition called Parkinson’s disease dementia. This condition is marked by a decline in thinking, reasoning, and problem-solving. Parkinson’s disease is a progressive ...

The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.

Obstructive sleep apnea (OSA) was linked with an increased risk of Parkinson's disease, but continuous positive airway ...